Keyphrases
Pediatric Patients
100%
Papillary Thyroid Carcinoma
100%
Sustained Response
100%
RET Fusion
100%
Selpercatinib
100%
NCOA4-RET
100%
Dose Reduction
50%
Young Female
50%
Therapeutic Approaches
50%
Weight Gain
50%
Tyrosine Kinase Inhibitor
50%
2-dose
50%
Pediatric Thyroid Carcinoma
50%
Children with Cancer
50%
Thyroid Cancer
50%
Mediastinal Lymphadenopathy
50%
Pulmonary Nodule
50%
Gene Rearrangement
50%
Selective Inhibition
50%
Supplemental Oxygen
50%
Oxygen Demand
50%
Radioactive Iodine
50%
Molecular Landscape
50%
RET Gene
50%
Metastatic Papillary Thyroid Carcinoma
50%
Medicine and Dentistry
Pediatrics Patient
100%
Papillary Thyroid Cancer
100%
Biological Marker
25%
Pediatrics
25%
Thyroid Cancer
25%
Radioactive Iodine
25%
Mediastinal Lymphadenopathy
25%
Lung Nodule
25%
Gene Rearrangement
25%
Pediatric Cancer
25%
Tyrosine-Kinase Inhibitor
25%
Drug Dose Reduction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Papillary Carcinoma
100%
Biological Marker
25%
Thyroid Cancer
25%
Elimination
25%
Protein Tyrosine Kinase Inhibitor
25%
Lymphadenopathy
25%
Radioactive Iodine
25%
Lung Nodule
25%